4//SEC Filing
Zuga Matt 4
Accession 0001576885-24-000026
CIK 0001576885other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 7:05 PM ET
Size
4.9 KB
Accession
0001576885-24-000026
Insider Transaction Report
Form 4
Zuga Matt
CFO & Chief Business Officer
Transactions
- Sale
Common Stock
2024-01-18$3.71/sh−4,242$15,717→ 211,445 total
Footnotes (1)
- [F1]Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2023.
Documents
Issuer
Acumen Pharmaceuticals, Inc.
CIK 0001576885
Entity typeother
Related Parties
1- filerCIK 0001790214
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 7:05 PM ET
- Size
- 4.9 KB